Onychomycosis Treatment Market
- 2026 年市場規模
- USD 3,755 Mn
- 2033 年預估規模
- USD 5,497 Mn
- 年複合成長率 CAGR
- 5.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Onychomycosis Treatment Market, By Treatment Type (Drugs, Laser Therapy, and Photodynamic Therapy), By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, and Other Types), By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)
報告摘要
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit. For treatment, drugs remain the first-line treatment choice owing to a consistently high success rate. A newer generation of oral antifungal agents (itraconazole and terbinafine) has replaced older therapies in the treatment of onychomycosis.
Market Dynamics
Risk of onychomycosis in diabetic patient or increase in prevalence of diabetes, growing geriatric population, increase in demand for safe and effective treatment, rise in focus on the development of novel onychomycosis treatments, and growing awareness among people about potential threats of onychomycosis and available treatments are major factors expected to drive growth of the global onychomycosis treatment market over the forecast period.
For instance, in April 2021, Alembic Pharmaceuticals Limited (Alembic) announced that its joint venture Aleor Dermaceuticals Limited (Aleor) received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Efinaconazole Topical Solution for the treatment of onychomycosis in the toenail.
Moreover, in October 2020, Mundipharma launched the latest addition to its BETADINE range of infectious disease therapies. This BETADINE EMTRIX fungal nail solutions effectively treats the onychomycosis and improves the nail appearance after regular application.
Key features of the study
• This report provides in-depth analysis of the global onychomycosis treatment market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global onychomycosis treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Lumenis Ltd., Cipla Ltd., Bayer AG, Johnson & Johnson, Moberg Pharma AB, Pfizer Inc., Novartis, Galderma SA, Dr. Reddys Laboratories Ltd., Medimetriks Pharmaceuticals Inc., and Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global onychomycosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global onychomycosis treatment market.
Onychomycosis Treatment Market Segmentation
• By Treatment Type Insights (Revenue, USD Mn, 2020 - 2033)
o Drugs
o Laser Therapy
o Photodynamic Therapy
• By Type Insights (Revenue, USD Mn, 2020 - 2033)
o Distal Subungual Onychomycosis
o White Superficial Onychomycosis
o Proximal Subungual Onychomycosis
o Other Types
• By Region Insights (Revenue, USD Mn, 2020 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players in the Onychomycosis Treatment Market
o Lumenis Ltd.
o Cipla Ltd.
o Bayer AG
o Johnson & Johnson
o Moberg Pharma AB
o Pfizer Inc.
o Novartis
o Galderma SA
o Reddys Laboratories Ltd.
o Medimetriks Pharmaceuticals Inc.
o Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.)
o Others.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Treatment Type
Market Snapshot, By Type
Market Snapshot, By Geography
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Increasing prevalence of onychomycosis around the world
Availability of alternative treatment options
Rise in demand for safe/effective onychomycosis treatment
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product launch/Approvals
o PEST Analysis
o PORTER’s Analysis
o Merger and Acquisition Scenario
4. Global Onychomycosis Treatment Market, By Treatment Type, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Laser Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Photodynamic Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
5. Global Onychomycosis Treatment Market By Type, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Distal Subungual Onychomycosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o White Superficial Onychomycosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Proximal Subungual Onychomycosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Other Types
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
6. Global Onychomycosis Treatment Market By Geography, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
o U.S.
o Canada
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
o U.K.
o Germany
o France
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
o China
o Japan
o Australia
o India
o ASEAN
o South Korea
o Rest of Asia Pacific
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
o Mexico
o Brazil
o Rest of Latin America
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
o GCC
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2033, (USD Mn)
o South Africa
o Rest of Middle East, and Africa
7. Competitive Landscape
o Lumenis Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Cipla Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Moberg Pharma AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Novartis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Galderma SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Dr. Reddys Laboratories Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Medimetriks Pharmaceuticals Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Analyst Views
8. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們